Literature DB >> 20001488

Pattern of spread and prognosis in lower limb-onset ALS.

Martin R Turner1, Alice Brockington, Jakub Scaber, Hannah Hollinger, Rachael Marsden, Pamela J Shaw, Kevin Talbot.   

Abstract

Our objective was to establish the pattern of spread in lower limb-onset ALS (contra- versus ipsi-lateral) and its contribution to prognosis within a multivariate model. Pattern of spread was established in 109 sporadic ALS patients with lower limb-onset, prospectively recorded in Oxford and Sheffield tertiary clinics from 2001 to 2008. Survival analysis was by univariate Kaplan-Meier log-rank and multivariate Cox proportional hazards. Variables studied were time to next limb progression, site of next progression, age at symptom onset, gender, diagnostic latency and use of riluzole. Initial progression was either to the contralateral leg (76%) or ipsilateral arm (24%). Factors independently affecting survival were time to next limb progression, age at symptom onset, and diagnostic latency. Time to progression as a prognostic factor was independent of initial direction of spread. In a regression analysis of the deceased, overall survival from symptom onset approximated to two years plus the time interval for initial spread. In conclusion, rate of progression in lower limb-onset ALS is not influenced by whether initial spread is to the contralateral limb or ipsilateral arm. The time interval to this initial spread is a powerful factor in predicting overall survival, and could be used to facilitate decision-making and effective care planning.

Entities:  

Mesh:

Year:  2010        PMID: 20001488      PMCID: PMC3182546          DOI: 10.3109/17482960903420140

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  19 in total

1.  Collateral regeneration in partially denervated muscles.

Authors:  G WOHLFART
Journal:  Neurology       Date:  1958-03       Impact factor: 9.910

2.  Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients.

Authors:  P M Andersen; L Forsgren; M Binzer; P Nilsson; V Ala-Hurula; M L Keränen; L Bergmark; A Saarinen; T Haltia; I Tarvainen; E Kinnunen; B Udd; S L Marklund
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

3.  Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis.

Authors:  M T Hu; C M Ellis; A Al-Chalabi; P N Leigh; C E Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

4.  Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS.

Authors:  P G Ince; J Evans; M Knopp; G Forster; H H M Hamdalla; S B Wharton; P J Shaw
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

5.  Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

Authors:  M R Turner; A Hammers; A Al-Chalabi; C E Shaw; P M Andersen; D J Brooks; P N Leigh
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

6.  Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation.

Authors:  M Weber; A Eisen; H G Stewart; P M Andersen
Journal:  Brain       Date:  2000-07       Impact factor: 13.501

Review 7.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

8.  Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002.

Authors:  M R Turner; M J Parton; C E Shaw; P N Leigh; A Al-Chalabi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

9.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

Authors:  L J Haverkamp; V Appel; S H Appel
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

10.  Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

Authors:  M R Turner; A Cagnin; F E Turkheimer; C C J Miller; C E Shaw; D J Brooks; P N Leigh; R B Banati
Journal:  Neurobiol Dis       Date:  2004-04       Impact factor: 5.996

View more
  28 in total

1.  Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Authors:  Robert Küffner; Neta Zach; Raquel Norel; Johann Hawe; David Schoenfeld; Liuxia Wang; Guang Li; Lilly Fang; Lester Mackey; Orla Hardiman; Merit Cudkowicz; Alexander Sherman; Gokhan Ertaylan; Moritz Grosse-Wentrup; Torsten Hothorn; Jules van Ligtenberg; Jakob H Macke; Timm Meyer; Bernhard Schölkopf; Linh Tran; Rubio Vaughan; Gustavo Stolovitzky; Melanie L Leitner
Journal:  Nat Biotechnol       Date:  2014-11-02       Impact factor: 54.908

2.  Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.

Authors:  Christina Schuster; Elisabeth Kasper; Judith Machts; Daniel Bittner; Jörn Kaufmann; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo
Journal:  J Neurol       Date:  2013-08-31       Impact factor: 4.849

3.  Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis.

Authors:  Christina Schuster; Elisabeth Kasper; Judith Machts; Daniel Bittner; Jörn Kaufmann; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo
Journal:  J Neurol       Date:  2014-07-15       Impact factor: 4.849

4.  Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Michael Lee; Jong Seok Bae; Eneida Mioshi; Cindy S-Y Lin; Casey M Pfluger; Robert D Henderson; Steve Vucic; Michael Swash; David Burke; Matthew C Kiernan
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

5.  Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS.

Authors:  Neil G Simon; Jim Lagopoulos; Sita Paling; Casey Pfluger; Susanna B Park; James Howells; Thomas Gallagher; Michel Kliot; Robert D Henderson; Steve Vucic; Matthew C Kiernan
Journal:  J Neurol       Date:  2017-03-06       Impact factor: 4.849

6.  Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michael Swash; George C Ebers
Journal:  Brain       Date:  2010-06-24       Impact factor: 13.501

7.  ALS-CSF-induced structural changes in spinal motor neurons of rat pups cause deficits in motor behaviour.

Authors:  Sanjay Das; A Nalini; T R Laxmi; T R Raju
Journal:  Exp Brain Res       Date:  2020-11-10       Impact factor: 1.972

8.  Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Authors:  John Ravits; Stanley Appel; Robert H Baloh; Richard Barohn; Benjamin Rix Brooks; Lauren Elman; Mary Kay Floeter; Christopher Henderson; Catherine Lomen-Hoerth; Jeffrey D Macklis; Leo McCluskey; Hiroshi Mitsumoto; Serge Przedborski; Jeffrey Rothstein; John Q Trojanowski; Leonard H van den Berg; Steven Ringel
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

9.  Venous thromboembolism in amyotrophic lateral sclerosis: a prospective study.

Authors:  Matthew Gladman; Melanie Dehaan; Hanika Pinto; William Geerts; Lorne Zinman
Journal:  Neurology       Date:  2014-04-11       Impact factor: 9.910

Review 10.  Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis.

Authors:  S Bräuer; V Zimyanin; A Hermann
Journal:  J Neural Transm (Vienna)       Date:  2018-02-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.